Article

The president and the pheochromocytoma.

St. Luke's-Roosevelt Hospital Center, New York, New York, USA.
The American Journal of Cardiology (Impact Factor: 3.43). 06/2007; 99(9):1325-9. DOI: 10.1016/j.amjcard.2006.12.043
Source: PubMed

ABSTRACT President Eisenhower experienced an acute heart attack in September 1955 and died of ischemic cardiomyopathy 14 years later. The autopsy revealed, unexpectedly, a 1.5-cm pheochromocytoma in the left adrenal gland. In view of these hitherto unreported findings, the investigators analyzed the blood pressure pattern of the president throughout his life. Although hypertension was documented on and off from 1930 until his death, it is unknown whether the pheochromocytoma was present during his presidency. During the later part of President Eisenhower's life, excessive systolic and diastolic blood pressure spikes were documented, although he concomitantly had severe ischemic cardiomyopathy. In conclusion, most likely, the pheochromocytoma was the underlying cause of this erratic blood pressure pattern and may have worsened the course of the president's ischemic cardiomyopathy.

0 Bookmarks
 · 
83 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: -The presence and severity of coronary artery calcified plaque (CAC) differs markedly between individuals of African and European descent, suggesting that admixture mapping (AM) may be informative for identifying genetic variants associated with subclinical cardiovascular disease (CVD). METHODS AND RESULTS: -AM of CAC was performed in 1,040 unrelated African Americans with type 2 diabetes mellitus from the African American-Diabetes Heart Study (AA-DHS), Multi-Ethnic Study of Atherosclerosis (MESA), and Family Heart Study (FamHS) using the Illumina custom ancestry informative marker (AIM) panel. All cohorts obtained computed tomography scanning of the coronary arteries using identical protocols. For each AIM, the probability of inheriting 0, 1, and 2 copies of a European-derived allele was determined. Linkage analysis was performed by testing for association between each AIM using these probabilities and CAC, accounting for global ancestry, age, gender and study. Markers on 1p32.3 in the GLIS1 gene (rs6663966, LOD=3.7), 1q32.1 near CHIT1 (rs7530895, LOD=3.1), 4q21.2 near PRKG2 (rs1212373, LOD=3.0) and 11q25 in the OPCML gene (rs6590705, LOD=3.4) had statistically significant LOD scores, while markers on 8q22.2 (rs6994682, LOD=2.7), 9p21.2 (rs439314, LOD=2.7), and 13p32.1 (rs7492028, LOD=2.8) manifested suggestive evidence of linkage. These regions were uniformly characterized by higher levels of European ancestry associating with higher levels or odds of CAC. Findings were replicated in 1,350 AAs without diabetes and 2,497 diabetic European Americans from MESA and the Diabetes Heart Study. CONCLUSIONS: -Fine mapping these regions will likely identify novel genetic variants that contribute to CAC and clarify racial differences in susceptibility to subclinical CVD.
    Circulation Cardiovascular Genetics 12/2012; 6(1). DOI:10.1161/CIRCGENETICS.112.964114 · 5.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The article reviews current magnetic resonance imaging (MRI) techniques and illustrates the MRI features of the commonly encountered lesions of the adrenal gland. MR may not always be able to characterize an adrenal mass. In these instances, reviewing the patient's clinical history and prior imaging can usually differentiate benign from malignant lesions, even if you cannot establishing an exact tissue diagnosis. The reader is referred to other reviews of adrenal imaging that emphasizes the use of CT and imaging-management algorithms that are beyond the purview of this focused review (1-6).
    Journal of Magnetic Resonance Imaging 08/2012; 36(2):272-85. DOI:10.1002/jmri.23601 · 2.57 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Some historical figures have suffered endocrine diseases. This review relates those whose diseases have been published in the scientific literature. It takes a biographical summary and describes the disease process in those considered most relevant by the nature of the disease or the importance of the figure in the Spanish and Latin American context: the Pharaoh Akhenaten, Maximinus I, Bodhidharma, Sancho I of Leon, William the Conqueror, Enrique IV of Castile, Henry VIII, Mary Tudor, Carlos II of Spain, Pio Pico, Pedro II of Brazil, Eisenhower and J. F. Kennedy.
    Endocrinología y Nutrición 04/2014;